Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Yousuf Zafar
Proprotein Convertase Subtilisin/Kexin Type-9 (PCSK-9) Inhibitors Induced Liver Injury - A Retrospective Analysis
Journal of Community Hospital Internal Medicine Perspectives
Internal Medicine
Related publications
Lipoprotein(a) and Proprotein Convertase Subtilisin/Kexin Type 9 Inhibitors
Clinical Research in Cardiology Supplements
Nuclear Medicine
Radiology
Molecular Biology
Structural Biology
Imaging
Medicine
Lipoprotein(a) and Inhibitors of Proprotein Convertase Subtilisin/Kexin Type 9
Journal of Thoracic Disease
Pulmonary
Respiratory Medicine
Cost Effectiveness of Proprotein Convertase Subtilisin/ Kexin Type 9 (PCSK9) Inhibitors
Cardiovascular Disorders and Medicine
Lipoprotein Apheresis and Proprotein Convertase Subtilisin/Kexin Type 9 Inhibitors: Do We Have a Vanquishing New Strategy?
European Journal of Preventive Cardiology
Epidemiology
Cardiovascular Medicine
Cardiology
PCSK6 (Proprotein Convertase Subtilisin/Kexin Type 6)
Atlas of Genetics and Cytogenetics in Oncology and Haematology
Cancer Research
Oncology
Genetics
Hematology
Variations of the Proprotein Convertase Subtilisin/Kexin Type 9 Gene in Coronary Artery Disease
Journal of International Medical Research
Biochemistry
Medicine
Cell Biology
Proprotein Convertase Subtilisin Kexin Type 9 Null Mice Are Protected From Postprandial Triglyceridemia
Arteriosclerosis, Thrombosis, and Vascular Biology
Cardiovascular Medicine
Cardiology
Management of Patients Eligible for Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9) Inhibitors: Economic Impact and Reform Proposals
Global and Regional Health Technology Assessment
Health Policy
Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9) Deficiency Is Protective Against Venous Thrombosis in Mice
Scientific Reports
Multidisciplinary